Hemagen Diagnostics, Inc. (HMGN)
OTCMKTS · Delayed Price · Currency is USD
0.0202
0.00 (0.00%)
At close: Jan 9, 2026
Hemagen Diagnostics Market Cap
Hemagen Diagnostics has a market cap or net worth of $312.33 thousand as of January 23, 2026. Its market cap has increased by 179.86% in one year.
Market Cap
312.33K
Enterprise Value
n/a
Revenue
4.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since May 23, 1996, Hemagen Diagnostics's market cap has decreased from 20.30M to 312.33K, a decrease of -98.46%. That is a compound annual growth rate of -13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 312.33K | 9,975.19% |
| Dec 9, 2025 | 3.10K | 100.00% |
| Dec 28, 2022 | 1.55K | -98.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Path Holdings | 619.22K |
| Regenerative Medical Technology Group | 512.42K |
| Helix BioMedix | 449.42K |
| Actavia Life Sciences | 385.91K |
| Innovation Pharmaceuticals | 370.14K |
| Oncology Pharma | 334.65K |
| THC Farmaceuticals | 310.05K |
| Ampio Pharmaceuticals | 292.64K |